Original Article
Intermediate Uveitis: Causes and Systemic
Associations
Nazli Gul, Sana Ullah
Jan, Yousaf Jamal Mahsood, Tariq Shanam, Tahir Ali
Pak J Ophthalmol 2018, Vol. 34, No. 1
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . ..
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See end of article for authors affiliations …..……………………….. Correspondence to: Nazli Gul Department of Ophthalmology, Khyber Teaching Hospital, Peshawar Email: drnazli83@gmail.com |
Purpose: The purpose of this study was to analyze the patients for the
etiologies/ systemic associations of intermediate uveitis (IU) at a single
center. Study Design: Descriptive case series. Place and Duration of the Study: Department of Ophthalmology, Hayatabad Medical
Complex, Peshawar From 1st August 2010 to 31st July
2012. Materials and Methods: Data collected included demographics such as
gender, age at presentation, complete ocular examination including
intraocular pressure. Systemic examination including central nervous,
respiratory, gastrointestinal and cardiovascular systems was also performed.
Relevant investigations such as full blood count (FBC) with erythrocyte
sedimentation rate (ESR), syphilis serology (Venereal Disease Research
Laboratory (VDRL) test), Rheumatoid Factor (RF), antinuclear antibodies
(ANA), Toxoplasma antibodies (IgM, IgG), Mantoux test and chest x-rays with
radiology report were performed. SPSS version 16 was used for data analysis. Results: The study included 21 eyes of 21 patients with IU. Mean age of
patients was 34.7 years with male to female ratio of 15:6. The disease was
bilateral in 6 patients (28.6%). Nineteen cases (90.5%) were idiopathic with no
systemic association. Two patients (9.5%) with IU were diagnosed with
tuberculosis. Conclusion: Infectious causes must be ruled out in all cases of IU. Key words: Intermediate uveitis, systemic associations,
tuberculosis. |
Intermediate uveitis (IU) is defined as uveitis in which vitreous
is the major site of inflammation with or without peripheral vascular sheathing
and macular edema1. The International Uveitis Study Group (IUSG)
described IU to be an idiopathic inflammatory syndrome which mainly involves
the anterior vitreous, ciliary body and peripheral retina with minimal or no
anterior and chorioretinal signs2. The incidence is similar in both genders with no racial
predilection3. It can affect any age group but is commonly found in
third and fourth decades3. Diagnosis of IU is usually clinical.
Patients usually present with decreased visual acuity and/or floaters. There is
no pain, redness or photophobia. There are vitreous cells which outnumber
anterior chamber cells and pars plana exudates.
Usually IU is less commonly associated with a systemic disorder
and most of the cases remain idiopathic2,4-5. However, with laboratory
investigations and ancillary tests we may exclude an associated disorder. It has got associations with systemic
infectious diseases such as tuberculosis, syphilis, HTLV-1, toxocariasis,
sarcoidosis and multiple sclerosis6. Cause and any systemic
association need to be determined for proper management. Incomplete or improper
management is associated with higher incidence of ocular complications. Proper
management is required to save vision as well as life of the patients. That’s
why we conducted this study to reach to any cause or systemic association for
proper vision and life saving management.
MATERIALS
AND METHODS
This
descriptive case series was conducted at Ophthalmology department of Hayatabad
Medical Complex from 1st August 2010 to 31st July 2012.
The diagnosis of IU was made clinically and its systemic associations were
investigated according to standard criteria described by the Standardization of
Uveitis Nomenclature (SUN) Working Group1. All patients underwent
standardized thorough clinical history, complete ophthalmological examination
with systemic review, laboratory and radiological investigations. Laboratory
investigations included full blood count (FBC) with erythrocyte sedimentation
rate (ESR), syphilis serology (Venereal Disease Research Laboratory (VDRL)
test), Rheumatoid Factor (RF), antinuclear antibodies (ANA), Toxoplasma
antibodies (IgM, IgG) and Mantoux test and chest x-rays with a radiology
report. Cases of IU without a specific systemic disease were labeled as
idiopathic. More than +3 vitreous cells were described as severe vitritis.
Data
included gender, age, eye/eyes affected, clinical ocular & systemic
examination, chest x-rays findings and laboratory investigations. Medical
history and other systemic co-morbidities were also recorded.
IU in both genders with age 16 years or more with best corrected
visual acuity of less than 6/12 on Snellen’s visual acuity
chart were included in the study. Patients with anterior uveitis, posterior
uveitis and pan uveitis were excluded from the study. Patients who fulfill the
inclusion criteria were selected in this study via OPD. After the approval of
the study by ethical board, informed consent was taken from all patients. SPSS
version 16 was used for data analysis.
RESULTS
Table 1:
Total
Number of Patients (n) |
21 |
Mean
age (years) |
34.7
(min.17, max. 60, SD ± 1.07) |
Male
versus Female |
15
versus 6 (71.4% VS 28.6%) |
Laterality
at initial presentation |
Unilateral:
15 (71.4%) |
Bilateral:
6 (28.6%) |
N = number, Min = minimum, Max = maximum, % = percentage
The Demographic data is given in table 1. Nineteen patients
(90.5%) had idiopathic disease. The systemic examination and laboratory work up
was unremarkable in these patients. Two patients (9.5%) had pulmonary
tuberculosis based on chest X-rays and positive Mantoux test of 15 mm
induration. They had presenting best corrected visual acuity of 1.30 log MAR
(Snellen equivalent: 6/120) in comparison to 1.00 log MAR (6/60) in idiopathic
cases which is statistically significant (p < 0.05). The disease was
bilateral in both cases. They had severe vitritis with snow balls, macular
edema and peripheral retinal periphlebitis. There were no choroidal lesions
which are associated with intraocular tuberculosis.
DISCUSSION
Usually
IU is autoimmune in nature in the developed world while the situation in
developing countries is different7. There is limited data of
infectious associations especially tuberculosis with IU in the developed world8-10.
In our study tuberculosis was main association which is consistent with our
high tuberculosis incidence rate. We had 9.5% of cases with tuberculosis as
etiology of IU which is higher than Japan and USA with an incidence of 6.9% and
7.0% respectively5,11. A study by Parchand et al showed an
association of 46.7% with tuberculosis in IU7. A local study also showed
association with tuberculosis12.
In
our study tuberculosis associated IU has similar incidence in both gender with
a ratio of 1:1. Both patients with tuberculosis associated IU presented in
their 4th decades with a positive family history of tuberculosis.
This could be due to the living conditions and low socioeconomic status of our
study population. Tuberculosis associated IU presented with worse mean best
corrected visual acuity than idiopathic cases. This could be due to associated
macular edema. Peripheral periphlebitis usually occurs with multiple sclerosis13.
We experienced its occurrence in our cases associated with tuberculosis. None
of the idiopathic cases had periphlebitis. Tuberculosis association with
posterior uveitis (choroiditis) or panuveitis is more common than with IU in
international studies14-18.
In
endemic areas like Pakistan, tuberculosis should be excluded as a cause of IU.
Many ophthalmologists may not routinely investigate these patients for
tuberculosis which can lead to prolonged disease course with frequent
recurrences. Significant reduction in recurrences of tuberculosis associated IU
can be achieved by prompt diagnosis & treatment. It should be a
multidisciplinary approach to treat IU by ophthalmologist, infectionists &
immunologists with uveitis experience for better management, prognosis and
course of the disease.
Multiple
sclerosis has a strong association with IU in the Western population19-20.
But in our study no systemic findings warrant MRI or CSF analysis. We did not
perform MRI for patients with uveitis keeping in mind the low prevalence of
multiple sclerosis in our population. ANA & RF were negative in all
patients.
In
our study most cases were idiopathic like other studies in Asia & Western
countries. The prevalence of idiopathic IU is 70 – 90% in Africa, Europe and
USA11, 18-21. In spite of using all the investigating tools for
systemic associations, there is still commonly a local pathological process
than systemic in IU. With improved newer diagnostic tools the proportion of
idiopathic IU will be reduced22.
Patients having visual acuity of < 0.3
logMAR (< 6/12 on Snellen’s visual acuity chart) used to be usually
treated12. Now more aggressive treatment is advocated.
Various treatment options are local steroids (periocular or intravitreal), oral
steroids, immunomodulatary therapy, cryotherapy or indirect laser
photocoagulation to peripheral affected retina, pars plana vitrectomy with
induction of posterior hyloid separation and peripheral laser photocoagulation
to pars plana snow banks.12 Periocular injections are the preferred
route of treatment12. Intravitreal triamcinolone acetonide (IVTA)
is used to treat inflammation and cystoid macular edema associated with IU
which achieves high vitreous concentration as compared to periocular route23.
All
our IU patients received IVTA. In addition to IVTA, IU patients having
associated tuberculosis also received anti tuberculosis drugs for 9
months. They showed good response to
anti tuberculosis drugs with vitreous activity reduction to < +1 cells and
resolution of macular edema at final follow up visit at 120th day of
starting treatment. Peripheral peribhlebitis also showed resolution.
Our study has limitations due to small sample size of patients.
Secondly, referral bias as we got all these patients from certain specific
areas which didn’t show the true population representation. The strong thing is
that we got patients from all ethnic groups to our tertiary care teaching
hospital. However the results of our study were comparable with the studies in
other part of our region or the world which is quite significant.
CONCLUSION
It is recommended that in endemic areas like Pakistan, high
vigilance should be done to find out the infective causes of IU especially
tuberculosis. This will prevent visual loss associated with systemic disease
recurrences and decrease the disease burden, morbidity and cost of management.
Author’s Affiliation
Dr. Nazli Gul
Specialist Registrar,
Department of Ophthalmology,
Khyber Teaching Hospital (KTH), Peshawar
Dr. Sanaullah Jan
FCPS, FRCS (Edin), FRCS (Glasgow)
Professor, Khyber Institute of Ophthalmic Medical Sciences
(KIOMS),
Hayatabad Medical Complex (HMC), Peshawar
Dr. Yousaf Jamal Mahsood
FCPS, FICO, FRCS
Assistant Professor,
Lady Reading Hospital, Peshawar
Dr. Tariq Shahnam
FCPS, FRCS, Assistant Professor,
Peshawar Institute of Medical sciences (PIMS),
Peshawar
Dr. Tahir Ali
FCPS, Vitreo Retina Trainee,
Lady Reading Hospital (LRH), Peshawar
Role
of Authors
Dr. Nazli Gul
Proposed topic, basic study design, methodology, manuscript
writing, date collection.
Dr Sanaullah Jan
Date collection, statistical analysis and interpretation of
results.
Dr Yousaf Jamal Mahsood
Statistical analysis and interpretation of results.
Dr Tariq Shahnam
Statistical analysis and interpretation of results.
Dr Tahir Ali
Literature review & referencing and quality insurer.
REFERENCES
1.
Wakabayashi
T, Morimura Y, Miyamoto Y, Okada AA. Changing patterns of intraocular inflammatory diseases. Ocul
Immunol Inflamm. 2003; 11: 277– 286.
2.
Bloch
ME, Nussenblatt RB. International
Uveitis Study Group Recommendations for the Evaluation of Intraocular
Inflammatory Disease. Am J Ophthalmol. 1987; 103: 234–235.
3.
Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of Uveitis
in an urban population in Southern India. Indian J Ophthalmol. 2007; 55 (3): 173-83.
4.
Talin
BA, Saskia MM, Lamiss M, Wolfgang E, Klaus M, Herbert A. Uveitis - a rare disease often associated with systemic diseases
and infections- a systematic review of 2619 patients. Orphanet J Rare
Diseases, 2012; 7: 57.
5.
Jabs
DA, Nussenblatt RB, Rosenbaum JT. Standardization
of Uveitis (SUN) Working Group. Standardization of Uveitis Nomenclature for
Reporting Clinical Data. Results of the First International Workshop. Am J
Ophthalmol. 2005; 140: 509–516.
6.
Zierhut
M, Foster CS. Multiple sclerosis,
sarcoidosis and other diseases in patients with pars planitis. Dev Ophthalmol.
1992; 23: 41–47.
7.
Parchand
S, Tandan M, Gupta V, Gupta A. Intermediate
uveitis in Indian population. J Ophthal Inflamm Infect. 2011; 1: 65–70.
8.
Donaldson
MJ, Pulido JS, Herman DC, Diehl N, Hodge D. Pars planitis: A 20-year study of incidence, clinical features,
and outcomes. Am J Ophthalmol. 2007; 144: 812–817.
9.
De
Boer J, Berendschot TT, Van der DP, Rothova A. Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol.
2006; 141: 616–621.
10.
Biswas
J, Sudharshan S. Intermediate uveitis.
In: Gupta A, Gupta V, Herbort CP, Khairallah M (eds) Uveitis text and imaging.
Jaypee Brothers Medical Publishers, New Delhi, 2009.
11.
Smit
RL, Baarsma GS, De Vries J. Classification
of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int
Ophthalmol. 1993; 17: 71–75.
12.
Iqbal A, Jan S, Saeed N, Khan MD. Two years audit of admitted uveitis patients. Pak J Ophthalmol.
2003; 19 (4): 108-12.
13.
Manohar B, Rathinam SR. Intermediate Uveitis. Indian J Ophthalmol. 2010; 58 (1): 21-27.
14.
Chang
JH, Wakefield D. Uveitis: A global
perspective. Ocul Immunol Inflamm. 2002; 10: 263–279.
15.
Cimino
L, Herbort CP, Aldigeri R, Salvarani C, Bolardi L. Tuberculous uveitis, a resurgent and underdiagnosed diasease. Int
Ophthalmol. 2009; 29: 67–74.
16.
Bodaghi
B, LeHoang P. Ocular tuberculosis.
Curr Opin Ophthalmol. 2000; 11: 443–448.
17.
Hamade
IH, Tabbara KF. Complications of
presumed ocular tuberculosis. Acta Ophthalmol. 2010; 88: 905–909.
18.
Davis
EJ, Rathinam SR, Okada AA, Tow SL, Petrushkin H, et al. Clinical spectrum of tuberculous optic neuropathy. J Ophthalmic
Inflamm Infect. 2012; 2: 183–189.
19.
Raja
SC, Jabs DA, Dunn JP, Fekrat S, Machan CH, et al. Pars planitis: clinical features and class II HLA associations.
Ophthalmology, 1999; 106: 594–599.
20.
Malinowski
SM, Pulido JS, Folk JC. Long-term
visual outcome and complications associated with pars planitis. Ophthalmology,
1993; 100: 818–824.
21.
Khairallah
M, Yahia SB, Ladjimi A, Messaoud R, Zaouali S, et al. Pattern of uveitis in a referral centre in Tunisia, North Africa.
Eye, 2007; 21: 33–39.
22.
Sengun
A, Karadag R, Karakurt A, Saricaoglu MS, Abdik O, et al. Causes of uveitis in a referral hospital in Ankara, Turkey. Ocul
Immunol Inflamm. 2005; 13: 45–50.
23.
Sallam A, Richard MC, John HC, John RG, Richard A, Peter JM, Susan
L. Short-term safety and efficacy
of intravitreal triamcinolone acetonide for uveitic macular edema in children.
Arch Ophthalmol. 2008; 126 (2): 200-5.